This is Allison’s personal multiple myeloma story, and others may be different. Allison is a paid spokesperson for GSK.
The research team, led by Professors Kwong Yok-lam (front right) and Eric Tse Wai-choi (front left), successfully utilises ...
During a live event, Patrick Moore, MD, discussed the superior efficacy with ide-cel vs standard care in relapsed/refractory ...
Ajai Chari, MD, stresses the importance of making bispecific therapies more accessible at the community level to improve outcomes in multiple myeloma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback